TRUL — Trulieve Cannabis Income Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapSuper Stock

Annual income statement for Trulieve Cannabis, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	R2019 December 31st	R2020 December 31st	R2021 December 31st	R2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	253	522	938	1,218	1,129
Cost of Revenue
Gross Profit	192	386	569	695	593
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	139	303	738	1,168	1,345
Operating Profit	113	218	200	50.2	-216
Total Net Non Operating Interest Income / Expense
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	104	157	166	-19.2	-285
Provision for Income Taxes
Net Income After Taxes	53.1	63	19.6	-181	-433
Minority Interest
Net Income Before Extraordinary Items
Extraordinary Items
Net Income	53.1	63	18	-246	-527
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	53.1	63	18	-246	-527
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.46	0.563	0.194	-0.656	-1.19